Short Interest Buzzer: Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) Just Reported Increased Shorts

November 28, 2016 - By Clifton Ray   ·   0 Comments

Short Interest Buzzer: Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) Just Reported Increased Shorts

The stock of Bellerophon Therapeutics Incorporated (NASDAQ:BLPH) registered an increase of 31.35% in short interest. BLPH’s total short interest was 86,300 shares in November as published by FINRA. Its up 31.35% from 65,700 shares, reported previously. With 80,000 shares average volume, it will take short sellers 1 days to cover their BLPH’s short positions. The short interest to Bellerophon Therapeutics Incorporated’s float is 1.57%. The stock decreased 1.48% or $0.008 on November 25, hitting $0.552. Bellerophon Therapeutics Inc (NASDAQ:BLPH) has declined 74.56% since April 25, 2016 and is downtrending. It has underperformed by 80.58% the S&P500.

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The company has a market cap of $7.95 million. The Firm is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. It currently has negative earnings. The Firm is focused on the development of its nitric oxide therapy for patients with pulmonary hypertension , using its delivery system, INOpulse, with pulmonary arterial hypertension (PAH) as the lead indication.

BLPH Company Profile

Bellerophon Therapeutics, Inc., incorporated on October 17, 2013, is a clinical-stage therapeutics company. The Firm is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Firm is focused on the development of its nitric oxide therapy for patients with pulmonary hypertension (PH), using its delivery system, INOpulse, with pulmonary arterial hypertension (PAH) as the lead indication. The Firm also develops Bioabsorbable Cardiac Matrix (BCM).

More notable recent Bellerophon Therapeutics Inc (NASDAQ:BLPH) news were published by: Prnewswire.com which released: “Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics …” on October 26, 2016, also Quotes.Wsj.com with their article: “News Bellerophon Therapeutics Inc.BLPH” published on February 07, 2015, Globenewswire.com published: “Bellerophon Therapeutics Announces Management and Board Additions” on July 01, 2015. More interesting news about Bellerophon Therapeutics Inc (NASDAQ:BLPH) were released by: Globenewswire.com and their article: “Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I …” published on July 27, 2015 as well as Globenewswire.com‘s news article titled: “Bellerophon Therapeutics Announces Enrollment of the First Patient in the …” with publication date: June 16, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>